Aurobindo Pharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for AUROBINDO PHARMA, and what generic and branded alternatives to AUROBINDO PHARMA drugs are available?
AUROBINDO PHARMA has four hundred and eighty-one approved drugs.
There are nineteen tentative approvals on AUROBINDO PHARMA drugs.
Summary for Aurobindo Pharma
US Patents: | 0 |
Tradenames: | 372 |
Ingredients: | 346 |
NDAs: | 481 |
Patent Litigation for Aurobindo Pharma: | See patent lawsuits for Aurobindo Pharma |
PTAB Cases with Aurobindo Pharma as petitioner: | See PTAB cases with Aurobindo Pharma as petitioner |
Drugs and US Patents for Aurobindo Pharma
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aurobindo Pharma | CEFAZOLIN SODIUM | cefazolin sodium | INJECTABLE;INJECTION | 065395-002 | Aug 8, 2008 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Aurobindo Pharma | QUETIAPINE FUMARATE | quetiapine fumarate | TABLET, EXTENDED RELEASE;ORAL | 207655-005 | Nov 29, 2017 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Aurobindo Pharma | QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE | hydrochlorothiazide; quinapril hydrochloride | TABLET;ORAL | 078450-002 | Aug 24, 2007 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Aurobindo Pharma | EFAVIRENZ | efavirenz | CAPSULE;ORAL | 078064-002 | Dec 15, 2017 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Aurobindo Pharma Ltd | VALSARTAN | valsartan | TABLET;ORAL | 202223-001 | Jan 5, 2015 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Aurobindo Pharma | TORSEMIDE | torsemide | TABLET;ORAL | 078249-004 | Oct 17, 2007 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Aurobindo Pharma
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Aurobindo Pharma Usa | MAXZIDE-25 | hydrochlorothiazide; triamterene | TABLET;ORAL | 019129-003 | May 13, 1988 | 4,444,769 | ⤷ Try a Trial |
Aurobindo Pharma Usa | MAXZIDE | hydrochlorothiazide; triamterene | TABLET;ORAL | 019129-001 | Oct 22, 1984 | 4,105,783 | ⤷ Try a Trial |
Aurobindo Pharma Usa | MAXZIDE | hydrochlorothiazide; triamterene | TABLET;ORAL | 019129-001 | Oct 22, 1984 | 4,444,769 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for AUROBINDO PHARMA drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Delayed-release Tablets | 20 mg | ➤ Subscribe | 2015-06-03 |
Similar Applicant Names
Here is a list of applicants with similar names.